NCT01780662 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- From first dose up to 13 months.
- Other-event reporting threshold
- 0%
Adverse event reporting is collected routinely using case report forms. The SAE table reflects NCI Common Terminology Criteria for Adverse Events (CTCAEs) submitted by the institution, via expedited reporting (NCI AdEERs / CAeRs). The "AE Other" table reflects all CTCAEs collected excluding those that were reported as SAEs. Ineligible patients are excluded from reporting of adverse events.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Dose1.4mg/kg | 3 / 3 | 3 / 3 | 2 / 3 |
| Dose 1.8mg/kg | 37 / 42 | 28 / 42 | 2 / 42 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 42
- num Events
- 4
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Hemolytic uremic syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Pericardial effusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Dental caries
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 42
- num Events
- 3
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Non-cardiac chest pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Infections and infestations - Other- Specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Lung infection
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 42
- num Events
- 6
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Chest pain - cardiac
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Pericardial effusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Sinus tachycardia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 42
- num Events
- 0
- term
- Ear and labyrinth disorders - Other- Specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Ear pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Photophobia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 42
- num Events
- 3
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 42
- num Events
- 4
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Enterocolitis
Complete source fields
- description
- Adverse event reporting is collected routinely using case report forms. The SAE table reflects NCI Common Terminology Criteria for Adverse Events (CTCAEs) submitted by the institution, via expedited reporting (NCI AdEERs / CAeRs). The "AE Other" table reflects all CTCAEs collected excluding those that were reported as SAEs. Ineligible patients are excluded from reporting of adverse events.
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 3
- description
- Patients receive brentuximab vedotin IV over 30 minutes on day 1 and gemcitabine hydrochloride IV over 100 minutes on days 1 and 8. Treatment repeats every 21 days for up to 15 more courses in the absence of disease progression or unacceptable toxicity. Patients with CR after any course may go off protocol therapy for stem cell transplant. Brentuximab Vedotin: Given IV Gemcitabine Hydrochloride: Given IV
- id
- EG000
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 3
- serious Num At Risk
- 3
- title
- Dose1.4mg/kg
- deaths Num Affected
- 2
- deaths Num At Risk
- 42
- description
- Patients receive brentuximab vedotin IV over 30 minutes on day 1 and gemcitabine hydrochloride IV over 100 minutes on days 1 and 8. Treatment repeats every 21 days for up to 15 more courses in the absence of disease progression or unacceptable toxicity. Patients with CR after any course may go off protocol therapy for stem cell transplant. Brentuximab Vedotin: Given IV Gemcitabine Hydrochloride: Given IV
- id
- EG001
- other Num Affected
- 28
- other Num At Risk
- 42
- serious Num Affected
- 37
- serious Num At Risk
- 42
- title
- Dose 1.8mg/kg
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 42
- num Events
- 6
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Chest pain - cardiac
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Pericardial effusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Sinus tachycardia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 42
- num Events
- 0
- term
- Ear and labyrinth disorders - Other- Specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Ear pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Photophobia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 42
- num Events
- 3
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 42
- num Events
- 4
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Enterocolitis
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 42
- num Events
- 4
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Hemolytic uremic syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Pericardial effusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Dental caries
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 42
- num Events
- 3
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Non-cardiac chest pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 42
- num Events
- 1
- term
- Infections and infestations - Other- Specify
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 42
- num Events
- 2
- term
- Lung infection
- time Frame
- From first dose up to 13 months.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle